Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LUNG CANCER, SUSCEPTIBILITY TO
|
3 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.700 | 0 | ||||||||
Malignant Neoplasms
|
1641 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.040 | 0.750 | 4 | 2009 | 2015 | |||||
Primary malignant neoplasm
|
1374 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.040 | 0.750 | 4 | 2009 | 2015 | |||||
Breast Carcinoma
|
2793 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.030 | 1.000 | 3 | 2013 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.030 | 1.000 | 3 | 2013 | 2016 | |||||
Rheumatoid Arthritis
|
2387 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.030 | 0.667 | 3 | 2015 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
cervical cancer
|
268 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Cervix carcinoma
|
283 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Degenerative polyarthritis
|
247 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Esophageal carcinoma
|
272 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Familial Mediterranean Fever
|
82 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Gallbladder Carcinoma
|
75 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Glaucoma, Primary Open Angle
|
222 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Intervertebral Disc Degeneration
|
47 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Intervertebral disc disorder
|
19 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of gallbladder
|
81 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Malignant neoplasm of lung
|
1142 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Malignant tumor of cervix
|
245 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Multiple tumors
|
12 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Primary malignant neoplasm of lung
|
981 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Secondary malignant neoplasm of lymph node
|
188 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Squamous cell carcinoma of oropharynx
|
33 | 0.653 | 0.560 | 1 | 172658358 | upstream gene variant | C/T | snv | 0.49 | 0.010 | 1.000 | 1 | 2015 | 2015 |